BC Extra | Jan 14, 2020
Company News

Treadwell emerges with two clinical cancer compounds, $27M seed from Tio

Cancer play Treadwell debuted Monday as Tio Bioventures’s first portfolio company with $27 million in seed funding and a pair of differentiated oral small molecules that are already in the clinic. Founded last year, Tio...
BC Innovations | Aug 15, 2013
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Polo-like kinase 4 (PLK4; STK18) In vitro and mouse studies identified small molecule PLK4 inhibitors that could help treat breast cancer. Computational modeling,...
Items per page:
1 - 2 of 2